AMR
Clinical trials for AMR explained in plain language.
Never miss a new study
Get alerted when new AMR trials appear
Sign up with your email to follow new studies for AMR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients facing rejection
Disease control OngoingThis study tests a new drug called ALXN2030 in 45 adults who have had a kidney transplant and are experiencing antibody-mediated rejection (AMR). The goal is to see if the drug can help resolve signs of rejection seen on a kidney biopsy after one year of treatment. Participants w…
Matched conditions: AMR
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Penicillin allergy labels may fuel superbugs, study warns
Knowledge-focused OngoingThis study looks at how having a penicillin allergy record affects treatment and antibiotic resistance in patients hospitalized with COVID-19. Many people labeled as allergic to penicillin are not truly allergic, leading to use of less effective antibiotics that can drive resista…
Matched conditions: AMR
Sponsor: University of Leeds • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:45 UTC